Skip to main content
OpenTrials

Clinical trial condition

Advanced Breast Cancer

Explore clinical trials studying Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

170 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Advanced Breast Cancer trial results

Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

NCT03455270

Conditions
Adenocarcinoma, Advanced Breast Cancer, Breast Cancer, +16 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Stanford Women Cancer Center Stanford, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

NCT02657889

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +27 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 30 locations
View Trial Details
Completed

Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2

NCT02952729

Conditions
Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Nonsmall Cell Lung Cancer
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
View Trial Details
Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

NCT02580448

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +12 more
Locations
  • Wallace Tumor Institute- University of Alabama Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • University of Colorado Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers Lakewood, Colorado, United States
View all 36 locations
View Trial Details

Related conditions